Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorMassachusetts Eye and Ear Infirmary

About this trial

The study is about the importance of each follow-up visit after activating a new cochlear implant in addition to evaluating the effectiveness and efficiency of a new programming strategy from Cochlear Americas. Investigators are looking for patients who have recently selected Cochlear Americas as their cochlear implant manufacturer of choice for their upcoming surgery. The aim of this study is to determine if 1) patient outcomes remain stable when reducing follow-up appointments and 2) Cochlear's population mean mapping can produce similar outcomes with patients while additionally reducing appointment times. The hypothesis is that using population mean mapping and reducing the number of follow-up visits after activation will yield similar performance outcomes to a standard of care while decreasing the length of appointment times and number of appointments needed for each patient.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Postlingually deafened

Adults (18+)

New cochlear implant recipients with Cochlear Americas devices; identified prior to activation

Able to perform follow-up testing tasks (repeating words/sentences, indicating they heard a sound stimulus, completing questionnaires)

Disqualifiers

Patients who select other cochlear implant manufactured devices

Pre-lingually deafened

Multiple disabilities

Unable to perform follow-up testing tasks (repeating words/sentences, indicating they heard a sound stimulus, completing questionnaires)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Changes in traditional follow-up

    Other intervention

    Traditional follow-up includes the following visits after activation: 1-week, 1-month, 3-months, 6-months and 1 year. With the intervention used, the 1-week follow-up is removed.

  • Population mean mapping

    Other intervention

    Traditional mapping at activation involves the measurement of at least 5 electrodes (both T-levels and C-levels). The intervention uses a population mean mapping strategy where there is a pre-set dynamic range of 46 CL with a spot check of C-levels.

Treatment groups

48 Participants
are divided into 4 treatment groups
Group A: Population mean mapping, without 1 week follow-upExperimental treatment 2 interventions
Group B: Population mean mapping, traditional follow-upExperimental treatment 1 intervention
Group C: Traditional mapping*, without 1 week follow-upExperimental treatment 1 intervention
Group D: Traditional mapping, traditional follow-upNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Speech perception scores

Speech perception scores via CNC word lists (percentages) at each visit. Scores are from 0 to 100% with 100% being the best.

Time frame
1-year
2

Duration of programming session

Time spent programming (seconds) at each visit

Time frame
1-year

Secondary outcomes

1

Quality of Life questionnaire

Patient outcomes via the Cochlear Implant Quality of Life-35 Profile questionnaire at each visit. Scores are out of 35 points and higher scores indicate better quality of life.

Time frame
1-year
2

Soundfield detection thresholds

Change in soundfield detection thresholds (dB HL) between each visit. Detection thresholds should be between 20 and 35 dB HL and anywhere in that range is good.

Time frame
1-year
3

programming levels

Change in programming levels between each visit (converted measure from CL to charge units). There is no indication of good and bad with programming levels, we are just measuring what they are and how stable they are over time.

Time frame
1-year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.